New: CIBMTR Research Cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome following axicabtagene ciloleucel or brexucabtagene CAR-T: CIBMTR research data Read more: 🔗pubmed.ncbi.nlm.nih.gov/42537846/
CIBMTR
@cibmtr.bsky.social
Research organization, collaborating with the global scientific community to increase survival and enrich quality of life for patients needing cellular therapy. Learn more at cibmtr.org.
New: CIBMTR Research GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches Read more: 🔗pubmed.ncbi.nlm.nih.gov/42571736/
New: CIBMTR Research Challenges with expansion of cell and gene therapy: A call for system-level action Read more: 🔗pubmed.ncbi.nlm.nih.gov/42586370/
🚨 Secure your spot at #Tandem27! Join HCT, cellular therapy, and gene therapy professionals for cutting-edge science, expert education, and valuable networking. Orlando, FL | 📅 Feb. 17-20, 2027 Register: www.tandemmeetings.com/Registration...
New: CIBMTR Research Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: Results from the ACCESS trial Read more: 🔗 pubmed.ncbi.nlm.nih.gov/42616616/
New: BMT CTN Research Donor-specific transplant outcomes from BMT CTN 1702: A multicenter prospective biologic assignment trial Read more: 🔗pubmed.ncbi.nlm.nih.gov/42263667/
Looking to learn, connect, and collaborate? #Tandem27 brings together the HCT and cellular therapy community for four days of education, networking, and discovery. 📍 Orlando, FL | 📅 Feb. 17-20, 2027 Register: www.tandemmeetings.com/Registration...
New: BMT CTN Research Patient-reported outcomes in clinical trials: Lessons from the BMT CTN Read more: 🔗pubmed.ncbi.nlm.nih.gov/42641160/
Last chance! Abstract submissions for 2027 Tandem Meetings close tonight at 11:59 p.m. CT. If you've been putting finishing touches on your research, now's the time to submit for your chance to present. 📍Orlando, FL | Feb. 17-20, 2027 🔗www.tandemmeetings.com/Abstracts/Ab...
NEW: BMT CTN Research Interpreting cord blood transplant outcomes in BMT CTN 1702 Read more: 🔗pubmed.ncbi.nlm.nih.gov/42641163/
🚨 Don't miss your chance to submit an abstract for #Tandem27 Abstract submissions close tomorrow, Oct. 9, at 11:59 p.m. CT. Submit your latest research before time runs out! ⏰ 📍 Orlando, FL | Feb. 17-20, 2027 🔗 www.tandemmeetings.com/Abstracts/Ab...
📢 #Tandem27 registration is open! Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy. 📍 Orlando, FL | 📅 Feb. 17-20, 2027 Register: www.tandemmeetings.com/Registration...
⏳ The countdown is on! Abstract submissions for #Tandem27 close this Friday, Oct. 9, at 11:59 p.m. CT. Share your latest research and connect with leaders in HCT, cellular therapy, and gene therapy. 📍 Orlando, FL | Feb. 17-20, 2027 🔗 www.tandemmeetings.com/Abstracts/Ab...
NEW: CIBMTR Research Fertility preservation in 2026: Current landscape in Europe and the United States for children and adolescents undergoing HCT-recommendations on behalf of the Westhafen Intercontinental Group Read more: 🔗pubmed.ncbi.nlm.nih.gov/42120917/
Ready to connect with leaders across the field? #Tandem27 brings together experts in HCT, cellular therapy, and gene therapy for four days of education, collaboration, and networking. 📍 Orlando, FL 📅 Feb. 17-20, 2027 Register: www.tandemmeetings.com/Registration...
NEW: CIBMTR Research Haploidentical versus HLA-matched unrelated donors for HCT in acute leukemia Read more: 🔗 pubmed.ncbi.nlm.nih.gov/42323086/
The future of HCT, cellular therapy, and gene therapy starts at #Tandem27. Join experts, researchers, and clinicians as they share the latest advances shaping patient care. 📍 Orlando, FL | 📅 Feb. 17-20, 2027 Register: www.tandemmeetings.com/Registration...
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more: www.tandemmeetings.com/Abstracts/Ab... @astct.bsky.social
NEW: CIBMTR Research Access challenges in alloHCT: Identifying at-risk US states by exploring social vulnerability, physician density, and unmet need Read more: 🔗pubmed.ncbi.nlm.nih.gov/42372215/
NOW AVAILABLE: 2014-2024 Non-Malignant Summary Slides. These slides detail the clinical practices, trends, and survival outcomes following HCT and cellular therapy, including gene therapy for non-malignant diseases. Learn more: cibmtr.org/CIBMTR/Resou...
NEW: CIBMTR Research Classical HLA allele and haplotype frequency estimates in US populations Read more: 🔗 pubmed.ncbi.nlm.nih.gov/42341485/
NEW: CIBMTR Research Newborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report Read more: 🔗pubmed.ncbi.nlm.nih.gov/42416786/
The wait is over. Registration for #Tandem27 is officially open! Join ASTCT and CIBMTR in Orlando, February 17-20, 2027, for the premier event in HCT, cellular therapy, and gene therapy. 📍 Orlando, FL 📅 February 17-20, 2027 Secure your spot today: www.tandemmeetings.com/Registration...
Could your research question change practice? Don't miss your chance to shape future research. There's only 1 week left to submit a proposal for consideration for a CIBMTR Working Committee study. 📅 Deadline: Monday, Sept. 21 🔗cibmtr.org/CIBMTR/Resea...
NEW: CIBMTR Research Infection burden in mismatched unrelated donor HCT: Results from the ACCESS Trial Read more: 🔗pubmed.ncbi.nlm.nih.gov/42448319/
💡 Your next research idea could help shape the future of transplantation and cellular therapy. CIBMTR is accepting Working Committee Study proposals from investigators interested in leading impactful observational research. 📅 Deadline: Monday, Sept. 21 Submit today: cibmtr.org/CIBMTR/Resea...
Visit our Study Summaries page to find what you need—clinical trials and trusted education tools, all in one place. New summaries are added regularly! Explore: cibmtr.org/summaries
Have a research question that could advance the field of cellular therapy? Submit a CIBMTR Working Committee study proposal for consideration at the 2027 Tandem Meetings. 📅 Deadline: Monday, Sept. 21 🔗 cibmtr.org/CIBMTR/Resea...
Abstract submission for #Tandem27 is now open! ASTCT and CIBMTR invite you to share your research with your HCT, cell, and gene therapy colleagues in Orlando, FL, February 17-20, 2027! Learn more www.tandemmeetings.com/Abstr.../Abs... @astct.bsky.social